Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026
Wolfgang Miesbach/LinkedIn,Jeffrey Weitz/photo:hamiltonhealthsciences.ca
Jul 27, 2026, 03:34

Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026

Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn:

”ISTH 2026, Paris — more than 6,800 delegates, the largest ISTH Congress in over a decade, and plenty of outstanding presentations.

One of my highlights was not in a lecture hall: it was on a small stage in the exhibition hall, in the ISTH New Frontier Forum.

Jeffrey Weitz laid out the whole case for FXI/XIa as a target:

  • Severe congenital FXI deficiency — bleeding after surgery or injury, almost none spontaneously; protection from ischaemic stroke and VTE, but not from myocardial infarction.
  • High FXI roughly doubles the risk of venous thrombosis; low FXI cuts arterial and venous events by half or more.
  • In animals, FXI inhibition blocks thrombosis without adding bleeding.
  • Dispensable for haemostasis, essential for clot propagation.

Credit to the format: 15–20 minutes, open stage, headphones, questions straight after, and microlearning modules on ISTH Academy to follow up.

No warm-up — reach the point and defend it.

More of this, please.”

Wolfgang Miesbach: A Standout Talk by Jeffrey Weitz at ISTH 2026

Stay updated with Hemostasis Today.

bleeding disorders FXI deficiency Health Hematology Hemostasis Hemostasis News Hemostasis Today ISTH 2026 Jeffrey Weitz Medicine stroke thrombosis VTE Wolfgang Miesbach
NewsFeed